Ziprasidone

규격

146939-27-7CAS 번호

928-541-6EC 번호

5-[2-[4-(1,2-benzothiazol-3-yl)piperazin-1-yl]ethyl]-6-chloro-1,3-dihydroindol-2-oneIUPAC 명칭

C21H21ClN4OS화학식

412.9 g/mol분자량

Ziprasidone; 146939-27-7; ziprasidona; Zipradon; ziprasidonum; 5-[2-[4-(1,2-benzothiazol-3-yl)piperazin-1-yl]ethyl]-6-chloro-1,3-dihydroindol-2-one; DTXSID4023753; 6UKA5VEJ6X; 2H-Indol-2-one, 5-[2-[4-(1,2-benzisothiazol-3-yl)-1-piperazinyl]ethyl]-6-chloro-1,3-dihydro-; CP-88059; DTXCID403753; CHEBI:10119; 5-{2-[4-(1,2-benzothiazol-3-yl)piperazin-1-yl]ethyl}-6-chloro-2,3-dihydro-1H-indol-2-one; ziprazidone; 2H-Indol-2-one, 5-(2-(4-(1,2-benzisothiazol-3-yl)-1-piperazinyl)ethyl)-6-chloro-1,3-dihydro-; CP-88,059; 5-(2-(4-(1,2-benzothiazol-3-yl)piperazin-1-yl)ethyl)-6-chloro-1,3-dihydroindol-2-one; CP-88,059-01; 5-(2-(4-(1,2-benzothiazol-3-yl)piperazin-1-yl)ethyl)-6-chloro-2,3-dihydro-1H-indol-2-one; RefChem:56241; N05AE04; 5-(2-(4-(3-benzisothiazolyl)piperazinyl)ethyl)-6-chloro-1,3-dihydro-2H-indol-2-one; Geodon; Ziprasidone (INN); C21H21ClN4OS; Ziprasidone free base; CP 88059; CHEMBL708; 5-(2-(4-(benzo[d]isothiazol-3-yl)piperazin-1-yl)ethyl)-6-chloroindolin-2-one; ZIPRASIDONE [INN]; MFCD06795476; Ziprasidone [INN:BAN]; 5-{2-[4-(1,2-benzothiazol-3-yl)piperazin-1-yl]ethyl}-6-chloro-1,3-dihydro-2H-indol-2-one; 5-[2-[4-(1,2-benzisothiazol-3-yl)-1-piperazinyl]ethyl]-6-chloro-1,3-dihydro-2H-indol-2-one; Zipradon (TN); CAS-146939-27-7; NCGC00186050-01; UNII-6UKA5VEJ6X; Ziprasidone NX; HSDB 7745; 5-(2-(4-(1,2-benzisothiazol-3-yl)-1-piperazinyl)ethyl)-6-chloro-1,3-dihydro-2h-indol-2-one; MFCD00866661; Ziprasidone Impurity 66; ZIPRASIDONE [MI]; 5-[2-[4-(1,2-benzothiazol-3-yl)piperazin-1-yl]ethyl]-6-chloro-1,3-dihydroindol-2-one;hydrate;hydrochloride; ZIPRASIDONE [HSDB]; GTPL59; C07568; ZIPRASIDONE [VANDF]; ZIPRASIDONE [MART.]; SCHEMBL28028; ZIPRASIDONE [WHO-DD]; MLS000759435; BIDD:GT0042; orb1226219; orb1311002; orb3141196; SCHEMBL29368426; Ziprasidone - Bio-X trade mark; HMS3742M19; ARD10222; MSK10222; Tox21_112194; Tox21_113525; BDBM50048803; EBC-27005; AKOS015900383; Tox21_112194_1; DB00246; FZ39584; SDCCGSBI-0633778.P001; T0031L2; 5-[2-[4-(1,2-benzothiazol-3-yl)piperazin-1-yl]ethyl]-6-chloro-indolin-2-one; 5-{2-[4-(1,2-benzisothiazol-3-yl)piperazin-1-yl]ethyl}-6-chloro-1,3-dihydro-2H-indol-2-one; NCGC00263539-01; NCGC00263539-03; NCGC00263539-04; NCGC00263539-05; NCGC00263539-13; AC-23360; BZ164575; HY-14542; SMR000466328; SY116115; NS00004565; Z0034; Z3463; Ziprasidone, 1mg/ml in 1,2-Dimethoxyethane; VU0286234-2; D08687; D92803; AB00639925-02; AB00639925-04; AB00639925_05; AB00639925_06; EN300-7415908; F842966; L000659; Q205517; BRD-K29582115-003-03-1; BRD-K29582115-066-01-2; 5-(2-(4-(benzo[d]isothiazol-3-yl)piperazin-1-yl)ethyl)-6-chloro-3H-indol-2-ol; 5-[2-(4-Benzo[d]isothiazol-3-yl-piperazin-1-yl)-ethyl]-6-chloro-1,3-dihydro-indol-2-one; 5-(2-(4-(1,2-benzisothiazol-3-yl)-1-piperazinyl)-ethyl)-6-chloro-1,3-dihydro-2H-indol-2-one; 5-(2-(4-(1,2-benzisothiazol-3-yl)-1-piperazinyl)ethyl)-6-chloro-1,3-dihydro-2H-indole-2-one; 5-[2-(4-Benzo[d]isothiazol-3-yl-piperazin-1-yl)-ethyl]-6-chloro-1,3-dihydro-indol-2-one (Ziprasidone); 5-[2-(4-Benzo[d]isothiazol-3-yl-piperazin-1-yl)-ethyl]-6-chloro-1,3-dihydro-indol-2-one(Norastemizole); 5-[2-[4-(1,2-Benzisothiazol-3yl)-1-piperazinyl]ethyl]-6-chloro-1,3-dihydro-2H-indol-2-one동의어